[Therapeutic results in chronic obstructive lung diseases].
D000328:Adult; D000336:Aerosols / Q000627:therapeutic use; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001784:Blood Gas Analysis; D001945:Breathing Exercises; D001987:Bronchiectasis / Q000150:complications; D001991:Bronchitis / Q000150:complications; D000697:Central Nervous System Stimulants / Q000627:therapeutic use; D002908:Chronic Disease; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D008171:Lung Diseases / Q000150:complications; D008297:Male; D008875:Middle Aged; D011656:Pulmonary Emphysema / Q000150:complications; D011660:Pulmonary Heart Disease / Q000209:etiology / Q000401:mortality; D012131:Respiratory Insufficiency / Q000188:drug therapy / Q000628:therapy*; D012138:Respiratory Therapy; D012122:Ventilators, Mechanical
D000336:Aerosols; D000900:Anti-Bacterial Agents; D000697:Central Nervous System Stimulants; D005938:Glucocorticoids
Behandlungsergebnisse bei chronisch-obstruktiven Lungenkrankheiten.